Surgical stimulation of uveoscleral outflow is an alternative to cyclodestructive procedures
DOI: 10.32364/2311-7729-2021-21-1-9-13
E.A. Korchuganova, A.Yu. Kazantzeva
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Aim: to assess clinical efficacy and safety of surgical scleral rejection (SSR) vs. transscleral diode laser cyclophotocoagulation (TSCPC) in primary open-angle glaucoma (POAG) and secondary glaucoma (SG).
Patients and Methods: study (prospective) group included 84 patients with POAG and SG after SSR. Control (retrospective) group included 80 patients after TSCPC. In addition, the patients were distributed by age and the stage and type of glaucoma, i.e., 128 patients were diagnosed with POAG and 36 patients were diagnosed with secondary thrombotic glaucoma. Follow-up was 24 to 36 months. IOP measurements, tonography (to assess the coefficient outflow facility / COF), ultrasound biomicroscopy of the anterior segment, visual acuity measurement, and visual field testing were performed.
Results: no complications after SSR were reported in patients with POAG and SG. In contrast, postoperative complications (choroidal effusion, hyphema, and uveitis) were reported in 14% of patients after TSCPC. Long-term IOP-lowering efficacy of both procedures was similar (87% after SSR and 89% after TSCPC). In POAG, greater IOP reduction was seen after TSCPC (by 39.11%) compared to SSR (by 31.58%) (p<0.05). Meanwhile, in patients with SG, treatment outcomes were similar (IOP reduced by 36.78% after TSCPC and by 35.26% after SSR). In long-term follow-up, PVF reduced by 10.76% vs. baseline after TSCPC but increased by 11.19% vs. baseline after SSR (p≤0.05). Surgery resulted in the improvement or stabilization of visual functions. Ultrasonography has demonstrated that outflow pathways (intrascleral space and filtering bleb) remain functional after SSR in long-term fol low-up.
Conclusion: SSR is an alternative to cyclodestructive procedures in POAG and SG. Sclera being the final point of the uveoscleral outflow is a perspective entity to develop surgical approaches to glaucoma treatment.
Keywords: surgical scleral resection, uveoscleral outflow, sclera, primary open-angle glaucoma, secondary glaucoma, glaucoma surgery, transscleral diode laser cyclophotocoagulation.
For citation: Korchuganova E.A., Kazantzeva A.Yu. Surgical stimulation of uveoscleral outflow is an alternative to cyclodestructive procedures. Russian Journal of Clinical Ophthalmology. 2021;21(1):9–13. DOI: 10.32364/2311-7729-2021-21-1-9-13.
2. Korchuganova E.A. Morphological features of the sclera in glaucoma. Russian Journal of Clinical Ophthalmology. 2017;4:227–230 (in Russ.). DOI: 10.21689/2311-7729-2017-17-4-227-230.
3. Nesterov A.P., Cherkasova I.N. Experimental study of additional ways of outflow of intraocular fluid. Ophthalmological Journal. 1976;2:14–15 (in Russ.).
4. Alekseev I.B., Moshetova L.K., Zubkova A.A. New non-penetrating operation-externalization of the scleral sinus with uveoscleral auto-drainage in the treatment of patients with primary open-angle glaucoma. Glaukoma. 2012;2:44–49 (in Russ.).
5. Kammer J.A., Mundy K.M. Suprachoroidal devices in glaucoma surgery. MEAJO. 2015;22(1):45–52. DOI: 10.4103/0974-9233.148348.
6. Frolov M.A., Frolov A.M., Kazakova K.A. Activation of the uveoscleral outflow pathway in the surgical treatment of glaucoma in combination with cataract. Oftal’mokhirurgiya. 2016;4:12–15 (in Russ.). DOI: 10.25276/0235-4160-2016-4-12-15.
7. Healthcare of Russia. 2019. The statistical compilation. Rosstat. 2019;1:91 (in Russ.).
8. Korchuganova E.A., Rumyantseva O.A., Egorov E.A. et al. Activation of the drainage function of the eye by resection. Russian Journal of Clinical Ophthalmology. 2015;3:127–130 (in Russ.).
9. Korchuganova E.A., Rumyantseva O.A., Nechetnykh S.Yu. The study of reparative processes of the tissues of the eyes after excimer laser ablation of the sclera with the aim of enhancing the outflow of aqueous humor (experimental study). Lazernaya meditsina. 2017;21(4):33–37 (in Russ.). DOI: 10.37895/2071-8004-2017-21-4-33-37.
10. Korchuganova E.A., Rumyantseva O.A., Kazantseva A.Yu. Technique and long-term results of surgical resection of the sclera in patients with primary glaucoma. Russian Journal of Clinical Ophthalmology. 2018;3:124–128 (in Russ.). DOI: 10.21689/2311-7729-2018-18-3-124-128.
11. Egorova E.V., Drobnitsa A.A., Uzunyan D.G. Assessment of the impact of laser energy of diode laser on the ciliary body in patients with a terminal painful glaucoma. Prakticheskaya meditsina. Oftal’mologiya. 2013;70:18–23 (in Russ.).
12. Ramli N., Htoon H.M., Ho C.L. et al. Risk factors for hypotony after trans-scleral diode cyclophotocoagulation. J. Glaucoma. 2012;21(3):169–173. DOI: 10.1097/IJG. 0b013e318207091.
13. Nguyen A.T., Maslin J.S., Noecker J.R. Early results of micropulse trans-scleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophtalmol. 2020;30(4):700–705. DOI: 10.1177/1120672119839303.
14. Frezzotti P., Mittica V., Martone G. et al. Long term follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta. Ophthalmol. 2010;88(1):150–155. DOI: 10.1111/j.1755-3768.2008.01354.
15. Tan A.M., Chockalingam M., Aquino M.C. et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin. Exp. Ophthalmol. 2010;38(3):266–272. DOI: 10.1111/j.1442-9071.2010.02238.
16. Ishida K. Update on results and complications of cyclophotocoagulation. Current Opinion in Ophthalmology. 2013;24(2):102–110. DOI: 10.1097/ ICU.0b013e32835d9335.
17. Shareef S., Rosenberg E., Nattis A., Nattis R. Transscleral Diode Laser Cyclophotocoagulation (CPC). In: Operative Dictations in Ophthalmology. Springer, Cham. 2017. DOI: 10.1007/978-3-319-45495-5_38.
18. Rotchford A.P., Jayasawal R., Madhusuhan S. et al. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94(9):1180–1183. DOI: 10.1136/bjo.2008.145565.
19. Kuroyedov A.V., Abysheva L.D., Aleksandrov A.S. et al. Tactics of managing patients with primary open-angle glaucoma in practice: options for drug, laser and surgical treatment. Mediko-biologicheskiye problemy zhiznedeyatel’nost. 2016;1(15):170–185 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
